KRAS Testing and Epidermal Growth Factor Receptor Inhibitor Treatment for Colorectal Cancer in Community Settings

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Community Settings ◽

Epidermal Growth ◽

Inhibitor Treatment ◽

Selecting Patients for Epidermal Growth Factor Receptor Inhibitor Treatment: A FISH Story or a Tale of Mutations?

Journal of Clinical Oncology ◽

10.1200/jco.2005.97.008 ◽

2005 ◽

Vol 23 (28) ◽

pp. 6813-6816 ◽

Cited By ~ 46

Author(s):

Bruce E. Johnson ◽

Pasi A. Jänne

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Inhibitor Treatment ◽

Clinical Pharmacokinetics and Pharmacodynamics of the Epidermal Growth Factor Receptor Inhibitor Panitumumab in the Treatment of Colorectal Cancer

Clinical Pharmacokinetics ◽

10.1007/s40262-017-0590-9 ◽

2017 ◽

Vol 57 (4) ◽

pp. 455-473 ◽

Cited By ~ 4

Author(s):

Sander Ketzer ◽

Kirsten Schimmel ◽

Miriam Koopman ◽

Henk-Jan Guchelaar

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Pharmacokinetics And Pharmacodynamics ◽

Clinical Pharmacokinetics ◽

Epidermal Growth ◽

PIK3CA Mutations Are Not a Major Determinant of Resistance to the Epidermal Growth Factor Receptor Inhibitor Cetuximab in Metastatic Colorectal Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-08-2961 ◽

2009 ◽

Vol 15 (9) ◽

pp. 3184-3188 ◽

Cited By ~ 217

Author(s):

Hans Prenen ◽

Jef De Schutter ◽

Bart Jacobs ◽

Wendy De Roock ◽

Bart Biesmans ◽

...

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Metastatic Colorectal Cancer ◽

Growth Factor Receptor ◽

Major Determinant ◽

Pik3ca Mutations ◽

Epidermal Growth ◽

KRASstatus and resistance to epidermal growth factor receptor tyrosine-kinase inhibitor treatment in patients with metastatic colorectal cancer: a meta-analysis

Colorectal Disease ◽

10.1111/codi.12749 ◽

2014 ◽

Vol 16 (11) ◽

pp. O370-O378 ◽

Cited By ~ 8

Author(s):

W. Li ◽

Q. Shi ◽

W. Wang ◽

J. Liu ◽

J. Ren ◽

...

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Inhibitor Treatment

Psychosocial Impact of Cutaneous Toxicities Associated With Epidermal Growth Factor Receptor-Inhibitor Treatment

Clinical Journal of Oncology Nursing ◽

10.1188/11.cjon.88-96 ◽

2011 ◽

Vol 15 (1) ◽

pp. 88-96 ◽

Cited By ~ 6

Author(s):

Kathryn J. White ◽

Jessica K. Roydhouse ◽

Kathleen Scott

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Psychosocial Impact ◽

Epidermal Growth ◽

Cutaneous Toxicities ◽

Inhibitor Treatment ◽

Economic impact in the management of dermatologic toxicities (dTs) induced by the epidermal growth factor receptor inhibitor (EGFRI) cetuximab in colorectal cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.3569 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 3569-3569 ◽

Cited By ~ 1

Author(s):

J. H. Borovicka ◽

M. F. Mulcahy ◽

C. Calahan ◽

D. P. West ◽

M. E. Lacouture

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Economic Impact ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Effective therapy of epidermal growth factor receptor inhibitor-associated dermatologic side effects in a patient with metastatic colorectal cancer: a and review of literature

Advances in Dermatology and Allergology ◽

10.5114/pdia.2012.30475 ◽

2012 ◽

Vol 4 ◽

pp. 324-329

Author(s):

Alicja Góralczyk ◽

Małgorzata Sokołowska-Wojdyło ◽

Anna Kowalczyk ◽

Aneta Szczerkowska-Dobosz ◽

Wioletta Barańska-Rybak

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Side Effects ◽

Epidermal Growth Factor ◽

Metastatic Colorectal Cancer ◽

Growth Factor Receptor ◽

Review Of Literature ◽

Epidermal Growth ◽

Trichomegaly of the eyelashes induced by the epidermal growth factor receptor inhibitor cetuximab in the treatment of metastatic colorectal cancer

BMJ Case Reports ◽

10.1136/bcr-2018-228968 ◽

2019 ◽

Vol 12 (4) ◽

pp. e228968 ◽

Cited By ~ 2

Author(s):

Leonor Vasconcelos Matos ◽

Ana Pissarra ◽

Mariana Malheiro ◽

Ana Neto Plácido

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Metastatic Colorectal Cancer ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

KRAS Mutational Status as a Predictor of Epidermal Growth Factor Receptor Inhibitor Efficacy in Colorectal Cancer

American Journal of Therapeutics ◽

10.1097/mjt.0b013e318199fa17 ◽

2009 ◽

Vol 16 (6) ◽

pp. 554-561 ◽

Cited By ~ 17

Author(s):

Roy D Baynes ◽

Jennifer Gansert

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Mutational Status ◽

Epidermal Growth ◽

Trichomegaly of the Eyelashes After Colorectal Cancer Treatment With the Epidermal Growth Factor Receptor Inhibitor Cetuximab

Clinical Colorectal Cancer ◽

10.3816/ccc.2009.n.040 ◽

2009 ◽

Vol 8 (4) ◽

pp. 235 ◽

Cited By ~ 6

Author(s):

Richard Bambury ◽

J.A. McCaffrey

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Treatment ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Colorectal Cancer Treatment ◽